Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis

Author:

Operario Darwin J.,Koeppel Alexander F.,Turner Stephen D.,Bao Yongde,Pholwat Suporn,Banu Sayera,Foongladda Suporn,Mpagama Stellah,Gratz Jean,Ogarkov Oleg,Zhadova Svetlana,Heysell Scott K.,Houpt Eric R.ORCID

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. WHO. Global Tuberculosis Report 2015. 2015.

2. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance;JP Cegielski;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2016

3. WHO. The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs 2016 [cited 2016 December, 2016]. Available from: http://www.who.int/tb/WHOPolicyStatementSLLPA.pdf.

4. Reaching consensus on drug resistance conferring mutations;DM Cirillo;Int J Mycobacteriol,2016

5. Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis;MA Yakrus;Tuberc Res Treat,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3